A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties

DOI: 10.1128/MCB.00357-18

Article Information

DOI

PubMed

Published By

History

^aAffiliated Cancer Hospital & Institute of Guangzhou Medical University, Xinzao Town, Panyu District, Guangzhou, Guangdong, China
^bLaboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Xinzao Town, Panyu District, Guangzhou, Guangdong, China
^cCentre for Clinical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
^dNational Engineering Research Center for Breeding Swine Industry, Guangdong Provincial Key Laboratory of Agro-Animal Genomics and Molecular Breeding, College of Animal Science, South China Agricultural University, Guangzhou, Guangdong, China
^eKey Laboratory of Cardiovascular Diseases, The Second Affiliated Hospital, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China

Address correspondence to Qingzhong Xiao, q.xiao{at}qmul.ac.uk, or Ning-Fang Ma, nfma{at}gzhmu.edu.cn.
Citation Liu S-S, Maguire EM, Bai Y-S, Huang L, Liu Y, Xu L, Fauzi I, Zhang S-Q, Xiao Q, Ma N-F. 2019. A novel regulatory axis, CHD1L-microRNA 486-matrix metalloproteinase 2, controls spermatogonial stem cell properties. Mol Cell Biol 39:e00357-18. https://doi.org/10.1128/MCB.00357-18.